Global Insulin Glargine Market Size To Worth USD 2.50 Billion By 2033 | CAGR OF 6.12% New York, United States , June 12, 2024 (GLOBE NEWSWIRE) -- The Global Insulin Glargine Market Size is to Grow from USD 1.38 Billion in 2023 to USD 2.50 Billion by 2033, at a Compound Annual Growth...

Global Insulin Glargine Market Size is projected to reach USD 2200 million by 2031, growing at a CAGR of 6.11%: Straits Research New York, United States, March 20, 2024 (GLOBE NEWSWIRE) -- Insulin glargine is a modified, long-acting form of medical insulin used to treat diabetes types I and II. It is subcutaneously injected....